Research Points To New Target For Stopping Colon Cancer
NewsRx.com
September 17, 2009
New research led by scientists at the University of North Carolina at Chapel Hill School of Medicine have found a drug target that suggests a potent way to kill colon cancers that resist current drugs aimed at blocking a molecule found on the surface of cells. Drugs that target the epidermal growth factor receptor, or EGFR, have been used for a number of cancers. But these drugs called EGFR inhibitors, such as cetuximab, have not been very effective against colon cancer.View Entire Article
Upcoming:
2010
- Portland, OR
- Colchester, VT
- Southeast Indiana
- Central Ohio
- Waukon, IA
- San Francisco, CA
- Austin, TX
- Des Moines, IA
- Alexandria, VA
2011
- Chattanooga, TN
- Fort Myers, FL
- Baton Rouge, LA
- Boston, MA
- Philadelphia, PA
- Winston-Salem, NC
- Wichita KS
- Cincinnati, OH
- Albany, NY
- Milwaukee, WI
- Houston TX